FDA.reportPublic FDA data

rucaparib 250 MG Oral Tablet

RxCUI
1921587
RxNorm name
rucaparib 250 MG Oral Tablet
Display name
rucaparib 250 MG Oral Tablet
Full name
rucaparib 250 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RubracaRUCAPARIBpharmaand GmbH0295d202-1cfe-7659-e063-6294a90a476e2025-12-31Warnings, Adverse reactionsExact identifier
rxcui: 1921587

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0295d202-1cfe-7659-e063-6294a90a476erucaparib 250 MG Oral Tablet [PSN] · rucaparib 250 MG Oral Tablet [SCD] · rucaparib (as rucaparib camisylate) 250 MG Oral Tablet [SY]319These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA. RUBRACA ® (rucaparib) tablets, for oral use Initial U.S. Approval: 201620251231